Two Key Drugs for 2017

Today we're bringing you an insightful article published by AJMC that highlights Dr. Aimee Tharaldson's picks for two new key drugs for 2017. Her top picks are Ocrevus, the first drug approved to treat primary progression MS and Dupixent, a drug we featured earlier this week that will help patients with severe atopic dermatitis.

Hear Dr. Tharaldson talk about these new drugs by clicking the link to the full article HERE! 

Performance Pharmacy Solutions (PPS) is a unique pharmacy benefit procurement platform developed by HORIZON Health Ventures to efficiently and effectively place, manage and oversee our self-funded client's pharmacy benefit management programs. The PPS platform provides turnkey solutions with proven market-leading PBM partners that offer, on average, 10-15% savings.

Ocrevus. This is going to be the first drug approved to treat primary progression MS. - See more at: http://www.ajmc.com/conferences/amcp-2017/dr-aimee-tharaldson-highlights-two-key-drugs-for-2017#sthash.Vc34Z7Iv.dpuf

Ocrevus. This is going to be the first drug approved to treat primary progression MS. - See more at: http://www.ajmc.com/conferences/amcp-2017/dr-aimee-tharaldson-highlights-two-key-drugs-for-2017#sthash.Vc34Z7Iv.dpufjj

Ocrevus. This is going to be the first drug approved to treat primary progression MS. - See more at: http://www.ajmc.com/conferences/amcp-2017/dr-aimee-tharaldson-highlights-two-key-drugs-for-2017#sthash.Vc34Z7Iv.dpuf

FDA Approves Treatment for Atopic Dermatitis

Pharmacy Times just released within the hour that the FDA has approved a treatment for moderate-severe Atopic Dermatitis. The drug is called Dupixent and it's an injection for patients that are unable to control the dermatitis with a topical cream.

Jennifer Barrett writes, "The FDA’s approval is based on data from the global LIBERTY AD clinical program, which included 3, phase 3 trials that examined the use of Dupixent either alone or with topical corticosteroids in patients with inadequately controlled moderate-to-severe AD. Dupixent alone or with topical corticosteroids met its primary and key secondary endpoints in all trials." 

Learn more about this new drug by reading the full article HERE! 

Performance Pharmacy Solutions (PPS) is a unique pharmacy benefit procurement platform developed by HORIZON Health Ventures to efficiently and effectively place, manage and oversee our self-funded client's pharmacy benefit management programs. The PPS platform provides turnkey solutions with proven market-leading PBM partners that offer, on average, 10-15% savings.

 

90 Is The New 30

Express Scripts just published a new article this new morning that highlights the concept of adherance in terms of prescription drugs. "Nonadherence is one of the country's most costly healthcare challenges, contributing more than $300 billion in pharmacy waste each year." It's important to note that taking medication as prescribed not only improves health outcomes for patients but also avoids waste from medications that weren't used as well additional medical care.

Express Scripts offers a tactical way to solve non-adherence. Interested to learn what it is? Read the full article HERE!

Performance Pharmacy Solutions (PPS) is a unique pharmacy benefit procurement platform developed by HORIZON Health Ventures to efficiently and effectively place, manage and oversee our self-funded client's pharmacy benefit management programs. The PPS platform provides turnkey solutions with proven market-leading PBM partners that offer, on average, 10-15% savings.

Nonadherence is one of the country’s most costly healthcare challenges, contributing more than $300 billion in pharmacy waste each year. - See more at: http://lab.express-scripts.com/lab/insights/pharmacy-options/90-is-the-new-30?hootPostID=f53bc0bca5b7aad08c9ad24a32c2db36#sthash.xgExPR86.dpuf

Nonadherence is one of the country’s most costly healthcare challenges, contributing more than $300 billion in pharmacy waste each year. - See more at: http://lab.express-scripts.com/lab/insights/pharmacy-options/90-is-the-new-30?hootPostID=f53bc0bca5b7aad08c9ad24a32c2db36#sthash.xgExPR86.dpuf

Omega-3 Fish Oil: Insufficient Evidence of Heart Disease Prevention

Jennifer Barrett of Pharmacy Times recently reported that American Heart Association published the findings of a new science advisory stating that there is not enough evidence to support that Omega-3 Fish Oil can prevent heart disease. However, Barrett writes, it may help to prevent death and hospitalization due to this disease.

“People in the general population who are taking omega-3 fish oil supplements are taking them in the absence of scientific data that shows any benefit of the supplements in preventing heart attacks, stroke, heart failure or death for people who do not have a diagnosis of cardiovascular disease,” David Siscovick, MD, MPH, chair of the writing committee of the new science advisory published in Circulation, said in a press release.

Learn more about this new finding HERE! 

Performance Pharmacy Solutions (PPS) is a unique pharmacy benefit procurement platform developed by HORIZON Health Ventures to efficiently and effectively place, manage and oversee our self-funded client's pharmacy benefit management programs. The PPS platform provides turnkey solutions with proven market-leading PBM partners that offer, on average, 10-15% savings.

Lower Prescription Drug Costs With These Easy Tips

The Steve Pomeranz Show website recently published an article and podcast that features Dr. Lynne Nowak, M.D., Medical Director of the Express Scripts Lab that helps consumers find ways to lower their prescription drug costs. The article hits topics including preferred pharmacy and a look into how pharmaceutical companies put prices on drugs. 

In the podcast Steve mentions a startling fact, "A recent survey demonstrated that 50% of consumers don’t know how to predict their own out-of-pocket healthcare costs, either presently or in the future. It also found that dealing with costs is the most stressful and difficult aspect of managing their healthcare." 

Click HERE to read the full article and to listen to the podcast. 

Performance Pharmacy Solutions (PPS) is a unique pharmacy benefit procurement platform developed by HORIZON Health Ventures to efficiently and effectively place, manage and oversee our self-funded client's pharmacy benefit management programs. The PPS platform provides turnkey solutions with proven market-leading PBM partners that offer, on average, 10-15% savings.

GOP Medicaid Overhaul Will Hit Insurers Where It Hurts

Shelby Livingston of Modern Healthcare recently wrote an article that highlighted how the new Affordable Care Act will completely change the landscape of Medicaid. Livingston writes,

"Legislation passed in two House committees last week would repeal the ACA and essentially roll back Medicaid expansion. That could result in 4 million to 6 million beneficiaries losing insurance between 2020 and 2024, slashing health insurers' premium revenue and, by proxy, earnings."

We will keep you updated on the latest as the headlines continue to come in. Read the full article HERE to stay informed. 

Performance Pharmacy Solutions (PPS) is a unique pharmacy benefit procurement platform developed by HORIZON Health Ventures to efficiently and effectively place, manage and oversee our self-funded client's pharmacy benefit management programs. The PPS platform provides turnkey solutions with proven market-leading PBM partners that offer, on average, 10-15% savings.

10 Rx Trends to Know Before ACC 2017

Today Express Scripts released today an article that highlights the 10 most important Rx trends for high blood pressure and high cholesterol in preparation for the 66th Annual American Cardiology (ACC) Scientific Sessions.

Take a look at the 10 spending trends for medications that treat high blood cholesterol and high blood pressure/heart disease:

1. Generics Matter
2. 1 in 10 Treat High Cholesterol
3. Nearly 20% Treat HBP/Heart Disease
4. The Cost of High Cholesterol
5. PCSK9 Trend
6. Good News - CVD Spending Expected to Decline
7. Nonadherence is Costly
8. Taking the Pulse of Exchange Plans
9. Monitoring Medicare
10. Monitoring Medicaid

Read the full article to learn about each trend in detail by clicking HERE!

Performance Pharmacy Solutions (PPS) is a unique pharmacy benefit procurement platform developed by HORIZON Health Ventures to efficiently and effectively place, manage and oversee our self-funded client's pharmacy benefit management programs. The PPS platform provides turnkey solutions with proven market-leading PBM partners that offer, on average, 10-15% savings.

Novel Technique Halves HIV Drug Dose

Lauren Santye of Pharmacy Times presented a new a technique that can decrease the drug dosage in HIV patients. Currently, patients have to take a daily oral dose, which can unfortunately lead to a high pill burden. The developmental therapies using Solid Drug Nanoparticle (SDN) technology will improve drug absorption in the body, resulting in the reduction of both dosages and cost per dose, allowing existing health care budgets to treat more patients. 

Read more about this new therapy HERE!

Performance Pharmacy Solutions (PPS) is a unique pharmacy benefit procurement platform developed by HORIZON Health Ventures to efficiently and effectively place, manage and oversee our self-funded client's pharmacy benefit management programs. The PPS platform provides turnkey solutions with proven market-leading PBM partners that offer, on average, 10-15% savings.

Drug Trend Report 2016

Today we're bringing you a video from Express Scripts that features a detailed analysis of U.S. drug prescription costs and utilization along with marketplace factors that may affect future changes. 

Check it out HERE!

Performance Pharmacy Solutions (PPS) is a unique pharmacy benefit procurement platform developed by HORIZON Health Ventures to efficiently and effectively place, manage and oversee our self-funded client's pharmacy benefit management programs. The PPS platform provides turnkey solutions with proven market-leading PBM partners that offer, on average, 10-15% savings.